BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26689204)

  • 21. Intranasal Delivery of RGD Motif-Containing Osteopontin Icosamer Confers Neuroprotection in the Postischemic Brain via αvβ3 Integrin Binding.
    Jin YC; Lee H; Kim SW; Kim ID; Lee HK; Lee Y; Han PL; Lee JK
    Mol Neurobiol; 2016 Oct; 53(8):5652-63. PubMed ID: 26482372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effects of amiodarone in a mouse model of ischemic stroke.
    Kotoda M; Ishiyama T; Mitsui K; Hishiyama S; Matsukawa T
    BMC Anesthesiol; 2017 Dec; 17(1):168. PubMed ID: 29216818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
    Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
    Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal Dexamethasone Reduces Mortality and Brain Damage in a Mouse Experimental Ischemic Stroke Model.
    Espinosa A; Meneses G; Chavarría A; Mancilla R; Pedraza-Chaverri J; Fleury A; Bárcena B; Pérez-Osorio IN; Besedovsky H; Arauz A; Fragoso G; Sciutto E
    Neurotherapeutics; 2020 Oct; 17(4):1907-1918. PubMed ID: 32632775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.
    Hanson LR; Roeytenberg A; Martinez PM; Coppes VG; Sweet DC; Rao RJ; Marti DL; Hoekman JD; Matthews RB; Frey WH; Panter SS
    J Pharmacol Exp Ther; 2009 Sep; 330(3):679-86. PubMed ID: 19509317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies.
    Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K
    Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic time window and dose dependence of neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats.
    Hasegawa Y; Morioka M; Hasegawa S; Matsumoto J; Kawano T; Kai Y; Yano S; Fukunaga K; Kuratsu J
    J Pharmacol Exp Ther; 2006 May; 317(2):875-81. PubMed ID: 16461588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Liu W; Jalewa J; Sharma M; Li G; Li L; Hölscher C
    Neuroscience; 2015 Sep; 303():42-50. PubMed ID: 26141845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxyresveratrol (trans-2,3',4,5'-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia.
    Andrabi SA; Spina MG; Lorenz P; Ebmeyer U; Wolf G; Horn TF
    Brain Res; 2004 Aug; 1017(1-2):98-107. PubMed ID: 15261105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain.
    Kim ID; Shin JH; Kim SW; Choi S; Ahn J; Han PL; Park JS; Lee JK
    Mol Ther; 2012 Apr; 20(4):829-39. PubMed ID: 22252450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia.
    Teramoto S; Miyamoto N; Yatomi K; Tanaka Y; Oishi H; Arai H; Hattori N; Urabe T
    J Cereb Blood Flow Metab; 2011 Aug; 31(8):1696-705. PubMed ID: 21487412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.
    Guan T; Liu Q; Qian Y; Yang H; Kong J; Kou J; Yu B
    Eur J Pharmacol; 2013 Aug; 714(1-3):303-11. PubMed ID: 23911884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol Preconditioning Induces a Novel Extended Window of Ischemic Tolerance in the Mouse Brain.
    Koronowski KB; Dave KR; Saul I; Camarena V; Thompson JW; Neumann JT; Young JI; Perez-Pinzon MA
    Stroke; 2015 Aug; 46(8):2293-8. PubMed ID: 26159789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory Effect of Glucagon Like Peptide-1 Receptor Agonist, Exendin-4, through Modulation of IB1/JIP1 Expression and JNK Signaling in Stroke.
    Kim S; Jeong J; Jung HS; Kim B; Kim YE; Lim DS; Kim SD; Song YS
    Exp Neurobiol; 2017 Aug; 26(4):227-239. PubMed ID: 28912645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice.
    Li L; Zhang X; Cui L; Wang L; Liu H; Ji H; Du Y
    Brain Res; 2013 Feb; 1497():32-9. PubMed ID: 23276496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PI3K/Akt pathway contributes to neuroprotective effect of Tongxinluo against focal cerebral ischemia and reperfusion injury in rats.
    Yu ZH; Cai M; Xiang J; Zhang ZN; Zhang JS; Song XL; Zhang W; Bao J; Li WW; Cai DF
    J Ethnopharmacol; 2016 Apr; 181():8-19. PubMed ID: 26805466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal delivery of HMGB1-binding heptamer peptide confers a robust neuroprotection in the postischemic brain.
    Kim ID; Shin JH; Lee HK; Jin YC; Lee JK
    Neurosci Lett; 2012 Sep; 525(2):179-83. PubMed ID: 22877697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective capabilities of TSA against cerebral ischemia/reperfusion injury via PI3K/Akt signaling pathway in rats.
    Ma XH; Gao Q; Jia Z; Zhang ZW
    Int J Neurosci; 2015 Feb; 125(2):140-6. PubMed ID: 24730998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of phosphoinositide-3-kinase/Akt pathway in propofol-induced postconditioning against focal cerebral ischemia-reperfusion injury in rats.
    Wang HY; Wang GL; Yu YH; Wang Y
    Brain Res; 2009 Nov; 1297():177-84. PubMed ID: 19703434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo.
    Nuñez-Figueredo Y; Ramírez-Sánchez J; Hansel G; Simões Pires EN; Merino N; Valdes O; Delgado-Hernández R; Parra AL; Ochoa-Rodríguez E; Verdecia-Reyes Y; Salbego C; Costa SL; Souza DO; Pardo-Andreu GL
    Neuropharmacology; 2014 Oct; 85():517-27. PubMed ID: 24953828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.